ESPERITE’S R&D division “The Cell Factory” implements GMP stem cell bioproduction technology and aims the cerebral palsy as first clinical trial

September 25, 2014 Group News

Esperite (Euronext.: ESP), the European leader in stem cells cryopreservation now entering the fields of predictive medicine and translational regenerative medicine R&D, implements its own proprietary new technology for clinical grade production of autologous mesenchymal and stromal stem cells in its business unit The Cell Factory.

Zutphen, The Netherlands – 25 September 2014

read more